Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan

Abstract

Congestive heart failure and metastatic infections were predictors of mortality. Isolates with decreased susceptibility to vancomycin that emerged during persistent MRSA bacteraemia were associated with mortality. Aggressive attempts to completely eradicate foci should be encouraged.

References

Page 1

	Year	Citations
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis Jingxiao Li, Daniel J. Sexton, Nathan W. Mick, Clinical Infectious Diseases	2000	4K
Gram-Negative Bacteremia William R. McCabe Archives of Internal Medicine Gram-negative BacteriologyPathogenic MicrobiologyAntimicrobial SusceptibilityAntibioticsMicrobial Disease	1962	1.4K
High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections Levita Hidayat, Donald Hsu, Ryan Quist, Archives of Internal Medicine	2006	848
Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia George Sakoulas, Pamela A. Moise-Broder, Jerome J. Schentag, Journal of Clinical Microbiology	2004	834
Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia Àlex Soriano, Francesc Marco, J. A. Martínez, Clinical Infectious Diseases	2007	764
Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant <i>Staphylococcus aureus</i> Endocarditis Donald P. Levine, Barbara S. Fromm, B. Ramesh Reddy Annals of Internal Medicine	1991	580
Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia Treated with Vancomycin Thomas P. Lodise, Jeffrey Graves, A. Evans, Antimicrobial Agents and Chemotherapy Mrsa CultureMrsa BacteremiaAntibiotic ResistanceVancomycin MicDrug Resistance	2008	551
Treatment Outcomes for Serious Infections Caused by Methicillin‐Resistant<i>Staphylococcus aureus</i>with Reduced Vancomycin Susceptibility Benjamin P. Howden, Peter Ward, Patrick G. P. Charles, Clinical Infectious Diseases Antimicrobial ChemotherapyReduced Vancomycin SusceptibilityAntibiotic ResistanceDrug ResistanceHealthcare-associated Infection	2004	483
Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy Pamela A. Moise-Broder, George Sakoulas, George M. Eliopoulos, Clinical Infectious Diseases Vancomycin TherapyVancomycin Selective PressureAntimicrobial SusceptibilityHealth SciencesAntibiotics	2004	330
Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia Benjamin P. Howden, Paul D. R. Johnson, Peter Ward, Antimicrobial Agents and Chemotherapy	2006	225

Page 1